应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
00874 白云山
交易中 06-30 13:28:46
14.260
-0.220
-1.52%
最高
14.660
最低
14.220
成交量
46.00万
今开
14.660
昨收
14.480
日振幅
3.04%
总市值
231.87亿
流通市值
31.36亿
总股本
16.26亿
成交额
658.23万
换手率
0.21%
流通股本
2.20亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
每周股票复盘:白云山(600332)终止人才公寓项目
证券之星 · 06-28 02:15
每周股票复盘:白云山(600332)终止人才公寓项目
白云山:公司闪充电解质水已上市,主要通过即饮渠道进行销售
证券之星 · 06-26
白云山:公司闪充电解质水已上市,主要通过即饮渠道进行销售
白云山:2025年度现金分红总额约为13.82亿元
证券之星 · 06-26
白云山:2025年度现金分红总额约为13.82亿元
白云山:公司经营、财务等各项指标均满足上市监管规定,不存在退市风险
证券之星 · 06-26
白云山:公司经营、财务等各项指标均满足上市监管规定,不存在退市风险
白云山:公司市净率较低是市场阶段性的估值表现
证券之星 · 06-26
白云山:公司市净率较低是市场阶段性的估值表现
白云山:公司高度重视市值表现与全体股东权益
证券之星 · 06-26
白云山:公司高度重视市值表现与全体股东权益
白云山:聚焦健康化、功能化等差异化细分赛道培育新品
证券之星 · 06-26
白云山:聚焦健康化、功能化等差异化细分赛道培育新品
白云山:持续推动业务稳定增长
证券之星 · 06-26
白云山:持续推动业务稳定增长
白云山:当前公司创新药研发管线推进有序
证券之星 · 06-26
白云山:当前公司创新药研发管线推进有序
白云山陈杰辉:企业对传统基础工人需求减少,对创新型人才需求大幅增加
睿见Economy · 06-23
白云山陈杰辉:企业对传统基础工人需求减少,对创新型人才需求大幅增加
白云山(600332)披露2026年度“提质增效重回报”行动方案,6月22日股价上涨0.14%
证券之星 · 06-22
白云山(600332)披露2026年度“提质增效重回报”行动方案,6月22日股价上涨0.14%
白云山(600332.SH)分公司收到头孢克洛缓释片(Ⅱ)药品注册证书
智通财经 · 06-10
白云山(600332.SH)分公司收到头孢克洛缓释片(Ⅱ)药品注册证书
一季度增收不增利,白云山调研透露王老吉多元化发展路径,推电解质水、果摇爽新品
深圳商报·读创 · 06-08
一季度增收不增利,白云山调研透露王老吉多元化发展路径,推电解质水、果摇爽新品
每周股票复盘:白云山(600332)Q1营收增3.85%但净利降2.06%
证券之星 · 06-07
每周股票复盘:白云山(600332)Q1营收增3.85%但净利降2.06%
白云山更新2026年5月股份变动月报表,股本维持稳定
公告速递 · 06-02
白云山更新2026年5月股份变动月报表,股本维持稳定
港股公告掘金 | 智谱拟发行A股并在科创板上市
智通财经 · 06-02
港股公告掘金 | 智谱拟发行A股并在科创板上市
新华健康丨白云山董事会换届:陈杰辉升任董事长 袁诚“一肩挑”副董事长与总经理
经济参考网 · 06-01
新华健康丨白云山董事会换届:陈杰辉升任董事长 袁诚“一肩挑”副董事长与总经理
白云山:白云山制药总厂获磷酸奥司他韦干混悬剂注册证书
财中社 · 06-01
白云山:白云山制药总厂获磷酸奥司他韦干混悬剂注册证书
股市必读:白云山(600332)5月29日披露最新机构调研信息
证券之星 · 06-01
股市必读:白云山(600332)5月29日披露最新机构调研信息
每周股票复盘:白云山(600332)2025年分红13.82亿,占比净利46.32%
证券之星 · 05-31
每周股票复盘:白云山(600332)2025年分红13.82亿,占比净利46.32%
加载更多
公司概况
公司名称:
白云山
所属市场:
SEHK
上市日期:
--
主营业务:
广州白云山医药集团股份有限公司是一家主要从事医药健康业务的中国公司。该公司通过四个分部运营。大南药分部从事中西成药、化学原料药、生物医药和天然药物等的研发、制造与销售。大健康分部从事饮料、食品、保健品等产品的生产、研发与销售。大商业分部从事医药产品、医疗器械、保健品等的批发、零售与进出口业务。大医疗分部从事医疗服务、中医养生、现代养老以及医疗器械产业的投资。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"00874","market":"HK","secType":"STK","nameCN":"白云山","latestPrice":14.26,"timestamp":1782797251570,"preClose":14.48,"halted":0,"volume":460000,"delay":0,"changeRate":-0.0151933701657459,"floatShares":219900000,"shares":1626000000,"eps":1.835,"marketStatus":"交易中","change":-0.22,"latestTime":"06-30 13:28:46","open":14.66,"high":14.66,"low":14.22,"amount":6582304,"amplitude":0.030387,"askPrice":14.27,"askSize":6000,"bidPrice":14.25,"bidSize":20000,"shortable":3,"etf":0,"ttmEps":2.059569,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1782807000000},"marketStatusCode":2,"adr":0,"listingDate":878140800000,"exchange":"SEHK","adjPreClose":14.48,"dividendRate":0.067013,"openAndCloseTimeList":[[1782783000000,1782792000000],[1782795600000,1782806400000]],"volumeRatio":0.655197,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600332","market":"SH","secType":"STK","nameCN":"白云山","latestPrice":20.04,"timestamp":1782797325000,"preClose":20.55,"halted":0,"volume":4908100,"delay":0,"premium":"-38.33"}},"requestUrl":"/m/hq/s/00874","defaultTab":"news","newsList":[{"id":"2646139593","title":"每周股票复盘:白云山(600332)终止人才公寓项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2646139593","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646139593?lang=zh_cn&edition=full","pubTime":"2026-06-28 02:15","pubTimestamp":1782584113,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,白云山报收于19.77元,较上周的20.78元下跌4.86%。本周,白云山6月23日盘中最高价报21.29元。本周关注点来自公司公告汇总:白云山终止广药白云山保障性租赁住房暨人才公寓建设项目。会议决定终止广药白云山保障性租赁住房暨人才公寓建设项目,原因为房地产市场环境变化及政策调整导致项目运营存在不确定性,终止项目预计不会对公司财务和经营状况产生重大不利影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000521.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0097","BK1191","BK0028","BK1521","BK1515","00874","BK1197","600332","BK0096","BK0070","BK0175","BK0239","BK0196","BK1606","BK0188","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646517353","title":"白云山:公司闪充电解质水已上市,主要通过即饮渠道进行销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2646517353","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646517353?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:18","pubTimestamp":1782465504,"startTime":"0","endTime":"0","summary":"证券之星消息,白云山(600332)06月26日在投资者关系平台上答复投资者关心的问题。投资者提问:请问公司上市的产品闪充电解质水在哪里能买的到?是太好卖了藏着卖,还是卖不掉不敢卖?白云山回复:尊敬的投资者您好,感谢您的关注!公司闪充电解质水已上市,主要通过即饮渠道进行销售,我们将继续推动上市新品的渠道渗透与销售放量。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600031655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0175","BK0188","BK1521","BK1191","BK0096","BK0070","BK0183","BK1515","600332","BK1606","BK0097","BK0239","BK0028","BK0196","BK1197","00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646353591","title":"白云山:2025年度现金分红总额约为13.82亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2646353591","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646353591?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:18","pubTimestamp":1782465497,"startTime":"0","endTime":"0","summary":"证券之星消息,白云山06月26日在投资者关系平台上答复投资者关心的问题。这是大多数人的共识,如果要是分红率高,证明所有人都看好公司未来发展,因为持续盈利,分红,但是如果还这么下去,路会越走越窄,产品更会没有人要,希望考虑清楚白云山回复:尊敬的投资者您好,感谢您的关注!2025年度,公司现金分红总额约为13.82亿元,占年度归属于股东的净利润的比例为46.32%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600031646.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0012","BK0070","BK1191","BK0097","600332","BK0183","BK0196","BK0175","BK1515","BK0028","BK1606","BK0096","BK1197","00874","BK1521","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646353521","title":"白云山:公司经营、财务等各项指标均满足上市监管规定,不存在退市风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2646353521","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646353521?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:18","pubTimestamp":1782465494,"startTime":"0","endTime":"0","summary":"证券之星消息,白云山(600332)06月26日在投资者关系平台上答复投资者关心的问题。投资者提问:公司这是准备退市了吗白云山回复:尊敬的投资者您好,感谢您的关注!公司经营、财务等各项指标均满足上市监管规定,不存在退市风险。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600031641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1606","BK0175","BK0096","BK1197","BK0070","BK1515","BK0097","BK0239","BK1191","BK0188","BK1521","BK0012","BK0028","00874","BK0196","600332","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646353546","title":"白云山:公司市净率较低是市场阶段性的估值表现","url":"https://stock-news.laohu8.com/highlight/detail?id=2646353546","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646353546?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:15","pubTimestamp":1782465347,"startTime":"0","endTime":"0","summary":"证券之星消息,白云山06月26日在投资者关系平台上答复投资者关心的问题。公司市净率较低是市场阶段性的估值表现,不存在国有资产流失风险;同时,公司经营、财务等各项指标均满足上市监管规定,不存在退市风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600031579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","00874","BK1191","BK0183","BK0028","BK1606","BK0239","BK0070","BK0012","600332","BK0196","BK0097","BK1515","BK1521","BK0175","BK0188","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646353557","title":"白云山:公司高度重视市值表现与全体股东权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2646353557","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646353557?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:15","pubTimestamp":1782465326,"startTime":"0","endTime":"0","summary":"证券之星消息,白云山(600332)06月26日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,公司股价创8年新低是真的吗?这是因为什么呢?白云山回复:尊敬的投资者您好,感谢您的关注!公司股价波动受多方面因素影响,公司高度重视市值表现与全体股东权益,将持续深耕主业、聚力提质增效,推动业务稳健向好发展,积极通过现金分红等方式回馈股东,并继续通过多种方式加强与投资者沟通、传递公司价值,全力提升企业内在价值,力争为投资者带来更好的投资回报。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600031563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK1515","600332","BK1606","00874","BK0188","BK0239","BK1197","BK1521","BK0096","BK0183","BK0097","BK0196","BK1191","BK0070","BK0028","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646353526","title":"白云山:聚焦健康化、功能化等差异化细分赛道培育新品","url":"https://stock-news.laohu8.com/highlight/detail?id=2646353526","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646353526?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:15","pubTimestamp":1782465326,"startTime":"0","endTime":"0","summary":"证券之星消息,白云山06月26日在投资者关系平台上答复投资者关心的问题。公司在稳固发展凉茶业务的同时,聚焦健康化、功能化等差异化细分赛道培育新品,在巩固刺柠吉、荔小吉等品类升级的基础上,重点推动果摇爽、闪充电解质水等已上市新品的渠道渗透与销售放量,积极培育第二增长曲线。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600031561.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","600332","BK0175","BK0183","BK1191","BK0097","BK1515","BK0188","BK1606","00874","BK1521","BK0096","BK1197","BK0028","BK0070","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646353588","title":"白云山:持续推动业务稳定增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2646353588","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646353588?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:15","pubTimestamp":1782465325,"startTime":"0","endTime":"0","summary":"证券之星消息,白云山(600332)06月26日在投资者关系平台上答复投资者关心的问题。投资者提问:公司股价创新低,公司管理层也没有对此任何解释和对应举措,是否不在乎资本市场?白云山回复:尊敬的投资者您好,感谢您的关注!公司及管理层始终高度关注资本市场表现与股东诉求,我们将持续推动业务稳定增长,积极通过现金分红等方式回馈股东,并继续通过多种方式加强与投资者沟通、传递公司价值,凝心聚力提升经营质量,力争为投资者创造更好的投资回报。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600031560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK0239","BK1521","BK0096","BK1515","BK0097","BK0175","BK0183","BK0196","BK0188","BK0028","BK0070","BK1197","00874","600332","BK0012","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646543353","title":"白云山:当前公司创新药研发管线推进有序","url":"https://stock-news.laohu8.com/highlight/detail?id=2646543353","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646543353?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:15","pubTimestamp":1782465313,"startTime":"0","endTime":"0","summary":"当前公司创新药研发管线推进有序,1类创新治疗领域涵盖慢性心力衰竭、妇科、抗感染、抗肿瘤、骨关节炎疾病等临床需求迫切的方向,着力满足未被充分满足的临床医疗需求,同时不断推进2类改良型新药研发工作。公司研发项目具体情况详见公司定期报告以及相关临时公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600031556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","06978","BK0239","BK0097","BK1191","BK0028","BK1521","00874","BK1197","600332","BK0096","BK0070","BK0196","BK1606","159992","BK0188","BK0183","BK0012","BK1161","BK1515","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645848768","title":"白云山陈杰辉:企业对传统基础工人需求减少,对创新型人才需求大幅增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2645848768","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645848768?lang=zh_cn&edition=full","pubTime":"2026-06-23 16:51","pubTimestamp":1782204660,"startTime":"0","endTime":"0","summary":" 6月23日,世界经济论坛第十七届新领军者年会在大连举行。广州白云山医药集团董事长陈杰辉表示,传统医药产业的就业空间正逐渐趋于紧张,而广药集团正坚定地走上创新转型的道路,这一战略转变直接重塑了企业对人才的实际需求结构。 陈杰辉直言,在这一转型过程中,企业对传统基础工人的使用量可能会有所减少;但与此同时,对具备高端研发能力、能够进行复杂思维的创新型人才的需求将会大幅增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/hy/hyjz/2026-06-23/doc-iniekvar6452460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0096","BK1606","BK0070","600332","BK1191","BK0097","BK1515","BK1521","BK0028","BK0012","BK0183","BK0188","BK0196","BK0175","BK1197","BK0239","00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645073528","title":"白云山(600332)披露2026年度“提质增效重回报”行动方案,6月22日股价上涨0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645073528","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645073528?lang=zh_cn&edition=full","pubTime":"2026-06-22 22:25","pubTimestamp":1782138317,"startTime":"0","endTime":"0","summary":"截至2026年6月22日收盘,白云山报收于20.81元,较前一交易日上涨0.14%,最新总市值为338.33亿元。该股当日开盘20.75元,最高20.84元,最低20.26元,成交额达1.58亿元,换手率为0.55%。近日,广州白云山医药集团股份有限公司发布《2026年度“提质增效重回报”行动方案》。公司重视投资者回报,持续实施稳定现金分红,2025年度拟每股派发现金红利0.45元(含税),全年分红每股0.85元,分红总额约13.82亿元,占归母净利润46.32%。公司自上市以来连续34次实施现金分红。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200038932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0239","BK1191","BK0196","BK0188","BK1197","600332","BK0175","BK0012","BK0028","BK0097","BK1515","BK0183","BK1521","00874","BK1606","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642542449","title":"白云山(600332.SH)分公司收到头孢克洛缓释片(Ⅱ)药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2642542449","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642542449?lang=zh_cn&edition=full","pubTime":"2026-06-10 16:25","pubTimestamp":1781079923,"startTime":"0","endTime":"0","summary":"智通财经APP讯,白云山(600332.SH)发布公告,近日,公司分公司广州白云山医药集团股份有限公司白云山制药总厂收到国家药品监督管理局核准签发的关于头孢克洛缓释片(Ⅱ)的《药品注册证书》。据悉,头孢克洛缓释片是第二代头孢菌素类药物,临床适用于敏感病原菌所致的下列感染:急性支气管炎和慢性支气管炎急性发作、咽炎、扁桃体炎、肺炎、鼻窦炎、单纯性下尿路感染、皮肤软组织感染。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452529.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1521","BK0028","BK0097","BK0183","BK0196","600332","00874","BK0012","BK1197","BK1515","BK1606","BK0096","BK0175","BK1191","BK0239","BK0070","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641038103","title":"一季度增收不增利,白云山调研透露王老吉多元化发展路径,推电解质水、果摇爽新品","url":"https://stock-news.laohu8.com/highlight/detail?id=2641038103","media":"深圳商报·读创","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641038103?lang=zh_cn&edition=full","pubTime":"2026-06-08 12:32","pubTimestamp":1780893131,"startTime":"0","endTime":"0","summary":"白云山(600332)6月5日最新公布的投资者关系活动记录表显示,该公司于5月1日至5月31日接受东吴证券、兴业自营、嘉实基金等多家机构的特定对象调研。该公司就投资者关注的研发创新、国际化布局、核心业务发展、财务状况及投资者回报等问题进行了回应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606083763204837.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["00874","600332","BK0175","BK0183","BK1521","BK0012","BK0188","BK0096","BK0196","BK0070","BK0097","BK0239","BK0028","BK1191","BK1197","BK1515","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641271771","title":"每周股票复盘:白云山(600332)Q1营收增3.85%但净利降2.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2641271771","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641271771?lang=zh_cn&edition=full","pubTime":"2026-06-07 02:46","pubTimestamp":1780771572,"startTime":"0","endTime":"0","summary":"截至2026年6月5日收盘,白云山报收于21.48元,较上周的21.52元下跌0.19%。本周,白云山6月2日盘中最高价报21.91元。白云山当前最新总市值349.22亿元,在中药板块市值排名4/66,在两市A股市值排名612/5206。机构调研要点公司2026年第一季度实现营业收入约232.78亿元,同比增长3.85%;归母净利润17.84亿元,同比下降2.06%。上市许可持有人为白云山制药总厂,生产单位为中山万汉制药有限公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060700000864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600332","00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160286142","title":"白云山更新2026年5月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1160286142","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160286142?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:36","pubTimestamp":1780389395,"startTime":"0","endTime":"0","summary":"2026年6月2日,广州白云山医药集团股份有限公司发布2026年5月股份变动月报表。报告期为2026年5月1日至5月31日。公告显示,公司法定/注册股本合计约16.26亿元,期内未有任何新增发行、购回、注销或库藏股活动,整体股本结构保持不变。公告同时披露,期内未有股权激励计划或期权变动,也未涉及任何其他股份变动事项。本次月报由公司秘书黄雪贞签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640995865","title":"港股公告掘金 | 智谱拟发行A股并在科创板上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2640995865","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640995865?lang=zh_cn&edition=full","pubTime":"2026-06-02 09:00","pubTimestamp":1780362051,"startTime":"0","endTime":"0","summary":"重大事项:丽珠医药:重组人促卵泡激素注射液获得《药品注册证书》山东新华制药股份:获得碳酸司维拉姆干混悬剂药品注册证书白云山:白云山制药总厂收到国家药监局核准签发的关于磷酸奥司他韦干混悬剂的《药品注册证书》智谱拟发行A股并在科创板上市驭势科技:与赛力斯凤凰智创完成行泊一体乘用车海外量产及交付澜起科技:横琴公司拟进行增资扩股并引入新投资方 引资合共约5亿元股东持续赋能!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448875.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2152927971.USD","LU0348816934.USD","LU0593848301.USD","LU0561508036.HKD","IE00BZ08YR35.GBP","BK1509","LU0211977185.USD","LU0541502299.USD","IE0032431581.USD","LU0231483743.USD","LU0359202008.SGD","XPEV","LU1226287529.USD","LU0072913022.USD","LU0588545904.SGD","LU0543330483.HKD","LU0708995153.HKD","LU0516422440.USD","BK1604","SG9999014674.SGD","SG9999015978.USD","BK1522","LU0821914370.USD","LU0259732245.USD","LU0572944931.SGD","LU0588546209.SGD","LU1993786604.SGD","LU0511384066.AUD","SG9999001226.SGD","NIO.SI","LU1960683339.HKD","LU0577902611.USD","09927","LU0327786744.USD","LU1282651048.USD","LU0149721374.USD","LU0505663152.USD","SG9999015945.SGD","BK1591","BK1587","LU0048597586.USD","LU2226246903.HKD","80175","BK1117","LU2039709279.SGD","LU2045819591.USD","LU0577902371.SGD","IE0008368742.USD","LU0164880469.USD","601127","LU0029874905.USD","BK1582","IE00BPRC5H50.USD","LU0140636845.USD","LU0918141705.HKD","LU0181495838.USD","LU0348827113.USD","LU0469268626.HKD","LU2242644610.SGD","03690","SG9999015986.USD","LU1064130708.USD","LU2360107325.USD","LU0117841782.USD","LU2249611893.SGD","LU0823038988.USD","LU2357125470.USD","LU0348735423.USD","07489","LU0164872284.USD","LU0856984785.SGD","LU2153592121.USD","LU0873338254.USD","IE00B0JY6N72.USD","LU0823414478.USD","LU0868486357.SGD","LU1328277881.USD","LU2148510915.USD","LU0633140727.USD","LU0164865239.USD","IE00B5MMRT66.SGD","82333","LU0516422952.EUR","SG9999001689.USD","LU1102505762.USD","LU2488822045.USD","01211","LU0577902538.SGD","00719","BK1540","688008","LU0828238088.HKD","LU0132412106.USD","LU1734074674.USD","LU0210526637.USD","LU1808992512.USD","LU1152091168.USD","LU0516422366.SGD","LU0244354667.USD","BK1191","MPNGY","LU0054450605.USD","SG9999000327.SGD","600332","LU1064131003.USD","LU1224709979.USD","BK1594","LU0143863784.USD","LU0823414551.USD","BK1606","LU0229945570.USD","IE00BD6J9T35.USD","BK1233","LU0320764599.SGD","LU0054237671.USD","LU0315178854.USD","LU1481107354.HKD","LU0499858438.USD","01511","000513","BYDDY","HMTD.SI","LU2476274720.SGD","BK1583","LU0289961442.SGD","LU0634319403.HKD","06809","LU0289960550.SGD","LU0672654166.SGD","LU1770034418.SGD","LU0289739343.SGD","LU0314109678.HKD","LU0509642566.USD","LU1303224171.USD","LU1242518931.SGD","002594","LU0326950275.SGD","LU0540923850.HKD","LU0589944569.HKD","LU0501845795.SGD","LU1675838814.USD","LU0315179316.USD","LU0196878994.USD","LU0531970944.HKD","SG9999015952.SGD","LU0320764243.SGD","LU0254981946.USD","BK1610","METmain","LU1105468828.SGD","LU1102505929.USD","LU0039217434.USD","LU0918141887.USD","LU2097828631.EUR","BK1575","SG9999000459.SGD","BK1142","LU2257852520.SGD","GELYY","LU2097828714.EUR","LU0871576103.HKD","LU0541501648.USD","BK1589","LU1242518857.USD","LU0633140560.USD","LU1688375341.USD","BK1521","LU0577902454.USD","LU0880133367.SGD","LU0417516738.SGD","SG9999002828.SGD","LU0823426480.USD","IE00B543WZ88.USD","SG9999002463.SGD","LU1152091754.HKD","LU0823039010.USD","LU2399975544.HKD","LU0605514214.HKD","LU1224444064.USD","LU1868837565.USD","IE0008369823.USD","02886","LU0449515922.USD","02513","LU1868837722.USD","BK1119","LU1961090484.USD","LU0287142896.SGD","LU0737861699.HKD","LU0456827905.SGD","NIO","LU0051755006.USD","81211","00175","LU0463099449.HKD","000756","LU0650527681.SGD","LU0878005551.USD","LU1023057109.AUD","LU0175139822.USD","LU0700851271.USD","LU0165289439.USD","IE00BF5LJ272.USD","BK1539","LU0326948709.USD","02333","LU0048580855.USD","LU0084288322.USD","LU0128522744.USD","LU0455707207.USD","LU1868838027.USD","IE00B031HY20.USD","LU0431992006.USD","LU0516423174.USD","LU1008478684.HKD","LU1831875114.USD","BK1221","BK1197","LU0047713382.USD","LU1328615791.USD","LU0531971595.HKD","LU0345775950.USD","LU0370786039.SGD","09866","LU0228659784.USD","LU1188198961.HKD","LU2097828805.USD","LU1048596156.SGD","LU0067412154.USD","LU0214875030.USD","LU1807302812.USD","SG9999002562.SGD","LU0173614495.USD","LU1719994722.HKD","LU0261950983.USD","LU0029875118.USD","01513","LU2125910500.SGD","LU0797268264.HKD","SG9999001903.USD","IE0034224299.USD","LU0823040885.USD","BK1615","LU0359201612.USD","LU0828237510.HKD","LU0143863198.USD","GWLLY","LU2476274308.USD","LU0708995583.HKD","LU0819121731.USD","LU0269904917.USD","LU1048588211.SGD","LU1861219969.SGD","LU2778985437.USD","LU1770036033.HKD","IE00BZ08YS42.EUR","09868","LU2449936058.SGD","LU1861214812.USD","LU1794554557.SGD","SG9999006597.SGD","LU0502904849.HKD","LU0611395673.USD","LU0049853897.USD","LU1282648689.USD","LU0577902298.EUR","LU0828237940.HKD","LU0516423091.SGD","LU0348788117.USD","LU1813983027.USD","LU0345776255.USD","LU0128522157.USD","LU0307460666.USD","LU0979878070.USD","LU2348774022.SGD","LU0043850808.USD","SG9999006514.SGD","LU0865486749.SGD","LU0011963245.USD","HYDD.SI","LU0417516902.SGD","LU0449509016.USD","LU0594300179.USD","BK1588","LU0348814723.USD","LU0823041008.USD","IE00B29SXG58.USD","LU0072462343.USD","LU0588545490.SGD","LU0823426308.USD","LU0594300419.USD","LU0683595622.HKD","LU0456846285.SGD","LU2097828557.USD","BK1163","LU0588545730.USD","LU1323998911.USD","LU0359201885.HKD","LU2506951792.HKD","09973","LU0106252389.USD","LU1282651121.HKD","LU0348805143.USD","LU0348825331.USD","LU2087589342.USD","LU1880383366.USD","BK1618","LU0293314216.USD","LU2097828474.EUR","601633","LU0320764755.SGD","00874","LU0543330566.HKD","BK1515","LU2294711713.HKD","LU1251922891.USD","LU0499858602.USD","IE00BZ08YT58.USD","LU0052750758.USD","LU1880383440.USD","LU1720050803.USD","EVS.SI","IE00B3M56506.USD","LU0251144936.SGD","LU0819123356.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640793002","title":"新华健康丨白云山董事会换届:陈杰辉升任董事长 袁诚“一肩挑”副董事长与总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2640793002","media":"经济参考网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640793002?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:54","pubTimestamp":1780307655,"startTime":"0","endTime":"0","summary":"白云山(600332.SH)新一届董事会落定。公司5月30日发布的公告显示,原董事长李小军因任期届满离任,原副董事长陈杰辉当选为新任董事长,原白云山汉方董事长袁诚升任副董事长并兼任总经理,原财务副总监刘菲接任财务总监。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606013756139786.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0188","BK0028","00874","BK0096","BK0070","BK0097","BK1521","600332","BK1606","BK0183","BK1515","BK0012","BK0196","BK1197","BK0175","BK1191","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640934492","title":"白云山:白云山制药总厂获磷酸奥司他韦干混悬剂注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2640934492","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640934492?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:19","pubTimestamp":1780301940,"startTime":"0","endTime":"0","summary":"6月1日,白云山(600332/00874)发布公告,公司分公司白云山制药总厂近日收到国家药品监督管理局核准签发的磷酸奥司他韦干混悬剂的《药品注册证书》。该药品的剂型为口服混悬剂,规格为0.36g,注册分类为化学药品3类,药品批准文号有效期至2031年5月26日。磷酸奥司他韦干混悬剂适用于成人和2周龄及以上儿童的甲型与乙型流感治疗,以及1岁及以上人群的流感预防。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606013756052487.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","00874","BK0028","BK1197","BK0183","600332","BK0196","BK0097","01477","BK0096","BK1191","BK1515","BK1574","BK0188","BK0070","BK0012","BK1606","BK0175","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640983935","title":"股市必读:白云山(600332)5月29日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2640983935","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640983935?lang=zh_cn&edition=full","pubTime":"2026-06-01 01:31","pubTimestamp":1780248669,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘,白云山报收于21.52元,上涨0.8%,换手率1.32%,成交量18.51万手,成交额4.01亿元。来自公司公告汇总:白云山于2026年5月29日完成董事会换届,陈杰辉当选董事长,袁诚任总经理。2025年以来,公司强化贴牌产品管理,出台相关管理制度,自2025年4月起全面停止新增对外商标授权,现存贴牌产品数量已大幅减少,后续将持续清退以保障品牌价值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100000642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["00874","600332","BK0175","BK0183","BK1521","BK0012","BK0188","BK0096","BK0196","BK0070","BK0097","BK0239","BK0028","BK1191","BK1197","BK1515","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639601443","title":"每周股票复盘:白云山(600332)2025年分红13.82亿,占比净利46.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2639601443","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639601443?lang=zh_cn&edition=full","pubTime":"2026-05-31 02:00","pubTimestamp":1780164042,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘,白云山报收于21.52元,较上周的21.64元下跌0.55%。本周关注点来自机构调研要点:公司2025年度分红方案已通过,全年拟派现约13.82亿元,占归母净利润的46.32%。截至目前,广药集团严格遵守相关承诺。为提高投资者报,公司于2024年开始增加分红频次并提高分红比例,并且公司2025年度分红方案已经董事会审议通过,包括2025年中期分红在内,公司2025年全年合计派发现金红利约13.82亿元,占2025年归属于公司股东净利润的比例为46.32%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100000415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0196","BK0028","BK0070","BK0097","BK0012","BK0096","BK0239","BK1515","BK1521","BK0183","600332","BK1606","00874","BK1191","BK1197","BK0175"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gybys.com.cn","stockEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":-0.0315},{"period":"3month","weight":-0.1055},{"period":"6month","weight":-0.1545},{"period":"1year","weight":-0.1179},{"period":"ytd","weight":-0.1545}],"compareEarnings":[{"period":"1week","weight":-0.0312},{"period":"1month","weight":-0.0856},{"period":"3month","weight":-0.0711},{"period":"6month","weight":-0.1016},{"period":"1year","weight":-0.0518},{"period":"ytd","weight":-0.1016}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"广州白云山医药集团股份有限公司是一家主要从事医药健康业务的中国公司。该公司通过四个分部运营。大南药分部从事中西成药、化学原料药、生物医药和天然药物等的研发、制造与销售。大健康分部从事饮料、食品、保健品等产品的生产、研发与销售。大商业分部从事医药产品、医疗器械、保健品等的批发、零售与进出口业务。大医疗分部从事医疗服务、中医养生、现代养老以及医疗器械产业的投资。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.009956},{"month":2,"riseRate":0.714286,"avgChangeRate":0.058376},{"month":3,"riseRate":0.586207,"avgChangeRate":0.049652},{"month":4,"riseRate":0.62069,"avgChangeRate":0.081835},{"month":5,"riseRate":0.551724,"avgChangeRate":0.044342},{"month":6,"riseRate":0.482759,"avgChangeRate":0.019708},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.016184},{"month":8,"riseRate":0.392857,"avgChangeRate":-0.036816},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.010726},{"month":10,"riseRate":0.428571,"avgChangeRate":0.004047},{"month":11,"riseRate":0.448276,"avgChangeRate":0.008322},{"month":12,"riseRate":0.535714,"avgChangeRate":0.023783}],"exchange":"SEHK","name":"白云山","nameEN":"BAIYUNSHAN PH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供白云山(00874)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"白云山,00874,白云山股票,白云山股票老虎,白云山股票老虎国际,白云山行情,白云山股票行情,白云山股价,白云山股市,白云山股票价格,白云山股票交易,白云山股票购买,白云山股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供白云山(00874)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}